- 收听数
- 0
- 性别
- 保密
- 听众数
- 18
- 最后登录
- 2021-3-22
- QQ
 - UID
- 765
- 阅读权限
- 20
- 帖子
- 1283
- 精华
- 0
- 在线时间
- 411 小时
- 注册时间
- 2012-10-21

- 科研币
- 7
- 速递币
- 271
- 娱乐币
- 2897
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
10速递币
题名 | Progression-free survival versus overall survival as the primary end point in anticancer drug trials: Increasingly relevant impact of therapy following progression | 作者 | Maurie Markman | 杂志 | January 2009, Volume 11, Issue 1, pp 1-2 | 链接 | http://link.springer.com/article/10.1007%2Fs11912-009-0001-y |
|
|